Chitosan as tear substitute: A wetting agent endowed with antimicrobial efficacy

Journal of Ocular Pharmacology and Therapeutics

Volumn 16, Issue 3, 2000, Pages 261-270

  Felt, O ^a   Carrel, A ^a   Baehni, P ^a   Buri, P ^a,b   Gurny, Robert ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Universities of Geneva and Lyon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CHITOSAN; PROTAGENT; WETTING AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG EFFECT; DRUG FORMULATION; DRUG SCREENING; DRY EYE; ESCHERICHIA COLI; LACRIMAL FLUID; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; VISCOSITY;

EID: 0034042901     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2000.16.261     Document Type: Article

References (19)

1. Holly, F.J. and Lemp, M.A. Tear physiology and dry eyes. Surv. Ophthalmol. 22:69-87, 1977.
2. Smolin, G. The role of tears in the prevention of infections. Int. Ophthalmol. Clin. 27:25-26, 1987.
3. Kulkarni, S.P., Bhanumathi, B., Thoppil, S.O., Bhogte, C.P., Vartak, D. and Amin, P.D. Dry eye syndrome. Drug Dev. Ind. Pharm. 23:465-471, 1997.
4. Holly, F.J. Diagnostic methods and treatment modalities of dry eye conditions. Int. Ophthalmol. 17:113-125, 1993.
5. Lopez Bernal, D. and Ubels, J.L. Artificial tear composition and promotion of recovery of the damaged corneal epithelium. Cornea 12:115-120, 1993.
6. Olson, R.J. and White, G.L. Preservatives in ophthalmic topical medications: A significant cause of disease. Cornea 9:363-364, 1990.
7. Felt, O., Furrer, P., Mayer, J.M., Plazonnet, B., Buri, P. and Gurny, R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int. J. Pharm. 180:185-193, 1999.
8. Lehr, C., Bouwstra, J.A., Schacht, E.H. and Jungiger, H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78:43-48, 1992.
9. He, P., Davis, S.S. and Illum, L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 166:68-75, 1998.
10. Staroniewicz, Z., Ramisz, A., Wojtasz-Pajak, A. and Brzeski, M.M. Studies on antibacterial and antifungal activity of chitosan. In Chitin World, Karnicki, Z.S., Brzeski, M.M., Bykowski, P.J. and Wojtasz-Pajak, A., eds, Wirtschaftsverlag, Bremerhaven, 1994, pp. 374-377.
11. Okamoto, Y., Tomita, T., Minami, S., Shigemesa, Y., Tanioka, S., Hamada, K., et al. Dramatic effect of chitosan on infection. In Chitin World, Karnick, Z.S., Brzeski, M.M., Bykowski, P.J. and Wojtasz-Pajak, A., eds, Wirtschaftsverlag, Bremerhaven, 1994, pp. 395-401.
12. Hyndiuk, R.A. and Snyder, R.W. Infectious diseases: Bacterial keratitis. In The Cornea, Smolin, G. and Thoft, R.A., eds, Little, Brown and Co., Boston, 1987, pp. 193-225.
13. Lee, K.Y., Ha, W.S. and Park, W.H. Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials 16:1211-1216, 1995.
14. Furrer, P., Mayer, J.M. and Gurny, R. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. Int. J. Pharm. submitted 1999.
15. Meseguer, G., Gurny, R., Buri, P., Rozier, A. and Plazonnet, B. Gamma scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine. Int. J. Pharm. 95:229-234, 1993.
16. Kälin, P. Contribution à la validation d'un test de tolérance oculaire sur la souris. Ph. D. Thesis, University of Lausanne, 1994.
17. Göbbels, M. and Spitznas, M. Effects of artificial tears on corneal epithelial permeability in dry eyes. Graefe's Arch. Clin. Exp. Ophthalmol. 229:345-349, 1991.
18. Muzzarelli, R.A.A., Tarsi, R., Filippini, O., Giovanetti, E., Biagini, G. and Varaldo, P.E. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob. Agents Chemother. 34:2019-2023, 1990.
19. Kristl, J., Smid-Korbar, J., Struc, E. Schara, M., and Rupprecht, H. Hydrocolloids and gels of chitosan as drug carriers. Int. J. Pharm. 99:13-19, 1993.